BackSelecta Biosciences Overview

Selecta Biosciences Current Cash

Track Selecta Biosciences's current cash ($120M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$118.64M
↓ 34.25% YoYΔ $-61.79M vs prior year quarter

Peer average

Loading

Selecta Biosciences Current Cash History

Loading

Selecta Biosciences vs. peers: Current Cash Comparison

Loading

Selecta Biosciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Selecta Biosciences (SELB) FAQ

Selecta Biosciences (SELB) currently reports a current cash of $120M as of March 2026. That compares with $180M in the prior-year period — down 34.2% year over year. Use the charts on this page to explore Selecta Biosciences's current cash history and peer comparisons.

Selecta Biosciences's current cash decreased from $180M to $120M — a 34.2% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Selecta Biosciences reported $120M in current cash as of March 2026. That compares with $180M in the prior-year period — down 34.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Selecta Biosciences, and consider following SELB for alerts when major investors trade the stock.

Selecta Biosciences is classified in the Healthcare sector. On current cash, it currently shows $120M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SELB with unrelated industries.